TocilizumabHypersensitivity reactions: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1711卷 / 1期

关键词：

D O I：

10.1007/s40278-018-49276-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：295 / 295

相关论文

共 50 条

[31] Obinutuzumab/rituximabInfusion related reactions: 4 case reports
Reactions Weekly, 2022, 1900 (1) : 259 - 259
[32] Adalimumab/etanercept/infliximabSkin reactions: 4 case reports
Reactions Weekly, 2012, 1417 (1) : 6 - 6
[33] Adalimumab/etanercept/infliximabSkin reactions: 4 case reports
Reactions Weekly, 2009, 1260 (1) : 6 - 6
[34] AzathioprineGastrointestinal reactions, myelosuppression and leucopenia: 4 case reports
Reactions Weekly, 2019, 1766 (1) : 70 - 70
[35] TocilizumabHypersensitivity and failed desensitisation: case report
Reactions Weekly, 2015, 1579 (1) : 377 - 377
[36] TocilizumabHypersensitivity, treated with desensitisation: case report
Reactions Weekly, 2015, 1574 (1) : 237 - 237
[37] TocilizumabHypersensitivity reaction with subsequent desensitisation: case report
Reactions Weekly, 2016, 1617 (1) : 220 - 220
[38] ACAM2000Cutaneous Reactions: 4 case reports
Reactions Weekly, 2017, 1633 (1) : 20 - 20
[39] Adalimumab/infliximab/rituximabVarious hypersensitivity reactions: 4 case reports
Reactions Weekly, 2015, 1543 (1) : 19 - 19
[40] Ofatumumab/rituximabInfusion reactions and widespread urticaria: 4 case reports
Reactions Weekly, 2017, 1633 (1) : 565 - 565

← 1 2 3 4 5 →